cancer-care
(4)
Bruno Lempernesse
Bruno Lempernesse is the CEO of MDClone, an Israeli-founded healthcare data platform that lets organizations explore and share sensitive patient data using synthetic data that preserves privacy. A 25-year veteran of healthcare technology, data science, and life sciences, he joined MDClone as President of North America in September 2024 and stepped up to Chief Executive Officer in 2025. Before MDClone he was CEO of Carevive, a cancer-care and real-world-studies company acquired by Health Catalyst in 2024, and earlier spent two decades at Cegedim building its data and research business, plus leadership roles at SHYFT Analytics and Acorn AI (a Medidata company). He is an early pioneer of longitudinal patient data drawn from electronic medical records across Europe and the United States.
Othman Ouenes
Othman Ouenes is the CEO and co-founder of Fidari, an oncology-first care infrastructure company whose name means 'in my home' in Arabic. A second-time healthcare founder, he previously co-founded QURE Healthcare (acquired by TRC Healthcare), where he spent roughly twelve years building clinical-measurement software. Born in France to a Moroccan mother and French-Algerian father and raised in the United States, he studied Human Biology at Stanford and now lives in Santa Fe, New Mexico, where he also serves as a part-time firefighter. Fidari combines AI-driven workflow automation with human navigation to help health systems coordinate supportive cancer care, capture billing, and connect patients to home-based services.
Brad Kreick
Brad Kreick is the CEO of AccessHope, a commercial venture spun out of City of Hope that connects local oncologists with subspecialist cancer experts at NCI-Designated Comprehensive Cancer Centers. After three decades moving between payers, providers and private equity - Oxford Health Plans, Apria Healthcare, SolutionHealth - he took the helm to turn a nonprofit cancer benefit into a national business, closing a $33 million Series B in 2024 and scaling AccessHope past 10 million covered members.
Othman Laraki
Othman Laraki is the co-founder and CEO of Color Health, a company he has steered from affordable genetic testing to pandemic-scale COVID infrastructure to a $4.6B-valued virtual cancer clinic serving over 7 million Americans. A Moroccan-born Stanford and MIT alumnus who learned to code by typing programs from magazines in Casablanca, he built Twitter's first revenue products as VP of Product before pivoting to healthcare. Today he sits on the American Cancer Society board as its only non-clinician, partners with Google and OpenAI to deploy AI in oncology, and angel invests in companies like Pinterest, Slack, and Instacart.